These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. Jeremias A; Baim DS; Ho KK; Chauhan M; Carrozza JP; Cohen DJ; Popma JJ; Kuntz RE; Cutlip DE J Am Coll Cardiol; 2004 Sep; 44(6):1210-4. PubMed ID: 15364321 [TBL] [Abstract][Full Text] [Related]
6. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). Harrington RA; Lincoff AM; Califf RM; Holmes DR; Berdan LG; O'Hanesian MA; Keeler GP; Garratt KN; Ohman EM; Mark DB J Am Coll Cardiol; 1995 Jun; 25(7):1693-9. PubMed ID: 7759725 [TBL] [Abstract][Full Text] [Related]
7. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945 [TBL] [Abstract][Full Text] [Related]
8. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes. Fuchs S; Gruberg L; Singh S; Stabile E; Duncan C; Wu H; Waksman R; Satler LF; Pichard AD; Kent KM; Kornowski R Am J Cardiol; 2001 Jul; 88(2):129-33. PubMed ID: 11448408 [TBL] [Abstract][Full Text] [Related]
10. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353 [TBL] [Abstract][Full Text] [Related]
11. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Leborgne L; Cheneau E; Pichard A; Ajani A; Pakala R; Yazdi H; Satler L; Kent K; Suddath WO; Pinnow E; Canos D; Waksman R Am Heart J; 2003 Sep; 146(3):501-6. PubMed ID: 12947370 [TBL] [Abstract][Full Text] [Related]
12. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis. Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions. Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosis. Ajani AE; Waksman R; Sharma AK; Lew R; Pinnow E; Canos DA; Cheneau E; Castagna M; Cha DH; Leborgne L; Satler LF; Pichard AD; Kent KM; Lindsay J Am J Cardiol; 2004 Feb; 93(3):313-7. PubMed ID: 14759380 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Lindsey JB; Kennedy KF; Stolker JM; Gilchrist IC; Mukherjee D; Marso SP; Pencina MJ; Kleiman NS; Cohen DJ Circ Cardiovasc Interv; 2011 Oct; 4(5):474-80. PubMed ID: 21972402 [TBL] [Abstract][Full Text] [Related]
17. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention. Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825 [TBL] [Abstract][Full Text] [Related]